Hishani Kirby

UCB Pharma (United Kingdom)United Kingdom

Medicine · Health Sciences

9h-index580citations13works0.02yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?


Research Topics

Monoclonal and Polyclonal Antibodies Research(7), Cell Adhesion Molecules Research(4), Biosimilars and Bioanalytical Methods(4), Bone health and osteoporosis research(2), Systemic Lupus Erythematosus Research(2)

Publications13 total

ABIRISK Consortium Recommendations for Terms and Definitions for Describing and Interpreting Unwanted Immunogenicity of Biopharmaceuticals
2015
A time-to-event model for the immunogenicity of certolizumab pegol in rheumatoid arthritis subjects
2015
Biophysical Journal·2004· 116 citedOpen Access
Journal of Biological Chemistry·2001· 48 citedOpen Access
Cell adhesion and communications/Cell adhesion and communication/Cell adhesion & communication·2000· 20 citedOpen Access
Biochemical individuality; variation in the urinary excretion of lysine, threonine, leucine, and arginine.
PubMed·1949· 5 cited

Frequent Co-authors

Joby K. Jose(3), Daniel Kramer(3), Sebastian Spindeldreher(3), Martyn K. Robinson(3), Martin J. Humphries(2), T. Albert(2), Matthieu Allez(2), Claudio Carini(2), Paul I. Creeke(2), Julie Davidson(2), Niek de Vries(2), Deborah Finco(2), Eva Havrdová(2), Agnès Hincelin-Méry(2), Elizabeth C. Jury(2), Sébastien Lacroix‐Desmazes(2), Julie Legrand(2), Enrico Maggi(2), Bernard Maillère(2), Claudia Mauri(2)